CTRI/2020/07/026515尚未招募3 期
A Phase-III, Open Label, Randomized Controlled Trial of Resveretrol-Copper Plus Standard Treatment Or Sodium-Copper-Chlorophyllin Plus Standard Treatment Versus Standard Treatment in Cancer patients with SARS-CoV-2 Infection who are Asymptomatic Or Mildly Symptomatic for Covid 19.
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Male and non-pregnant female cancer patients 18 years of age or older.
- •2. Positive reverse-transcriptaseâ??polymerase polymerase chain-reaction (RT-PCR) in a diagnostic specimen
- •3. Either asymptomatic or have only mild symptoms ((cough and/or fever and/or sore throat and/or other upper respiratory symptoms) at the time of study inclusion
- •4.Oxygen saturation of >94% while breathing ambient air, if this is measured
- •5.Either normal levels of haematological, liver and renal functions, and electrolytes OR no worse than Grade 1 (CTCAE Version 5.0) abnormalities in any of these parameters.
- •6. Patients with high blood sugar or glycosylated haemoglobin, of any degree will be eligible
- •7. Arterial blood gas, if done, should have normal values of pH, PO2, PCO2 and bicarbonate level.
排除标准
- •1.Cancer diagnosis not proven
- •2. Have pneumonia confirmed by chest imaging, 3. Have oxygen saturation (Sao2) of 94% or less while they were breathing ambient air
- •4.Have any Grade 2 or worse laboratory abnormality, including haematological, renal, liver, electrolyes.
研究者
相似试验
尚未招募
3 期
Randomized Controlled Trial Of Resveretrol-Copper Or Sodium-Copper-Chlorophyllin Vs Standard Treatment In Mild Covid-19 infectioCTRI/2020/05/025336Tata Memorial Centre
尚未招募
3 期
A study to find which drug (metoclopramide, thalidomide, prochlorperazine, or lorazepam) is best to treat vomiting due to chemotherapy in patients with cancer.CTRI/2024/08/072429Cancer Institute WIA
已完成
3 期
Phase III Controlled Trial of gMSC1 in Patients with Symptomatic Articular Cartilage Defects or Osteochondritis Dissecans in the KneeJPRN-jRCT1080223548TWOCELLS COMPANY, LIMITED70
进行中（未招募）
1 期
A trial comparing the pembrolizumab platinum based chemotherapy combination with pembrolizumab monotherapy in first line treatment of non small-cell lung cancer (NSCLC) patientsFirst line, stage IV non small-cell lung cancer (NSCLC) with PD L1 expression on =50 % of tumor cellsMedDRA version: 21.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2020-002626-86-FRCHRU de Brest292
已完成
3 期
Comparison of oral antidiabetic drugs with insulin in the treatment of Gestational Diabetes Mellitus.Reproductive Health and Childbirth - Fetal medicine and complications of pregnancyMetabolic and Endocrine - DiabetesGestational Diabetes MellitusACTRN12612001272886Dr Aisha Syed Wali154